← Browse by Condition
Medical Condition
salivary gland cancer
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
NCT04620187 Phase 2
Recruiting
Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
Enrollment
55 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT06805617 Phase 2
Recruiting
A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
Enrollment
35 pts
Location
United States
Sponsor
Glenn J. Hanna
NCT02012699
Recruiting
Integrated Cancer Repository for Cancer Research
Enrollment
999,999 pts
Location
United States
Sponsor
University of Nebraska